We are live on
!
Find out more
FA
FMA Advisory Portfolio holdings
AUM
$268M
1-Year Est. Return
30.8%
This Fund
S&P 500
This Quarter
Est. Return
+1.4%
1 Year Est. Return
+30.8%
3 Year Est. Return
+46.7%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$5.1M
(+2.3%)
Cap. Flow
+$3.24M
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
25.41%
Holding
149
New
7
Increased
81
Reduced
56
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.72M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$790K |
| 3 |
First Trust Value Line Dividend Fund
FVD
|
+$693K |
| 4 |
Cedar Fair
FUN
|
+$299K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$261K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.15M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$305K |
| 3 |
Emerson Electric
EMR
|
+$223K |
| 4 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$156K |
| 5 |
Citigroup
C
|
+$133K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.44% |
| 2 | Healthcare | 7.57% |
| 3 | Industrials | 7.38% |
| 4 | Consumer Staples | 7.11% |
| 5 | Technology | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$324B
| $2.65M | 1.15% |
32,985
-1,287
| -4% | -$103K |
|
27
Apple
AAPL
$4.89T
| $2.56M | 1.11% |
45,716
+2,448
| +6% | +$128K |
|
28
RTX Corp
RTX
$287B
| $2.5M | 1.09% |
29,141
+1,114
| +4% | +$92.5K |
|
29
T. Rowe Price
TROW
$25B
| $2.46M | 1.07% |
21,549
-107
| -0.5% | -$11.9K |
|
|
BSCL
30
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
| $2.39M | 1.04% |
112,512
-884
| -0.8% | -$18.8K |
|
31
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
| $2.36M | 1.03% |
36,880
-1,658
| -4% | -$105K |
|
32
Welltower
WELL
$178B
| $2.36M | 1.02% |
26,036
+101
| +0.4% | +$8.79K |
|
33
Automatic Data Processing
ADP
$100B
| $2.35M | 1.02% |
14,542
-259
| -2% | -$42.8K |
|
34
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.59B
| $2.32M | 1.01% |
50,807
-627
| -1% | -$28.9K |
|
35
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.32B
| $2.32M | 1.01% |
44,702
+229
| +0.5% | +$11.9K |
|
36
Lockheed Martin
LMT
$134B
| $2.27M | 0.99% |
5,826
+12
| +0.2% | +$4.51K |
|
37
iShares US Healthcare Providers ETF
IHF
$1.18B
| $2.25M | 0.98% |
69,595
-2,715
| -4% | -$93.4K |
|
38
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
| $2.2M | 0.96% |
30,070
-843
| -3% | -$61K |
|
39
Palo Alto Networks
PANW
$264B
| $2.14M | 0.93% |
62,970
-1,800
| -3% | -$63.7K |
|
40
Constellation Brands
STZ
$22.2B
| $2.06M | 0.9% |
9,951
+139
| +1% | +$27.9K |
|
41
TE Connectivity
TEL
$58.8B
| $2.05M | 0.89% |
22,020
-179
| -0.8% | -$16.5K |
|
42
PNC Financial Services
PNC
$100B
| $2.03M | 0.88% |
14,497
+395
| +3% | +$53.6K |
|
|
BSJK
43
DELISTED
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
| $1.92M | 0.83% |
80,301
+429
| +0.5% | +$10.3K |
|
44
Cummins
CMI
$91.7B
| $1.89M | 0.82% |
11,598
+757
| +7% | +$121K |
|
45
Altria Group
MO
$122B
| $1.88M | 0.82% |
45,930
-660
| -1% | -$30.4K |
|
|
46
Citigroup
C
$222B
| $1.83M | 0.79% |
26,444
-1,955
| -7% | -$133K |
|
|
BSCM
47
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $1.82M | 0.79% |
84,841
+416
| +0.5% | +$8.92K |
|
48
Enterprise Products Partners
EPD
$83.8B
| $1.78M | 0.77% |
62,334
+440
| +0.7% | +$12.8K |
|
49
Pfizer
PFE
$140B
| $1.64M | 0.71% |
48,207
-2,616
| -5% | -$95.1K |
|
50
Cohen & Steers Quality Income Realty Fund
RQI
$1.71B
| $1.52M | 0.66% |
96,057
+3,712
| +4% | +$54.5K |
|
Similar funds
DMK
HCIA
ISG
KCP
MCL
TPCM
DCM
SMR
FMA Advisory's Q3 2019 Portfolio in Review
As of Q3 2019, FMA Advisory held 149 positions worth $230M, up 2.3% from $225M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
FMA Advisory's Q3 2019 filing shows 7 new, 81 increased, 56 reduced and 1 closed positions. Its largest new stake was Bristol-Myers Squibb: 16,808 shares worth $852K. The largest sale was Johnson & Johnson, an estimated $1.15M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.
- FMA Advisory's largest Q3 2019 buy was Bristol-Myers Squibb: 16,808 shares worth $852K.
- FMA Advisory added most to CVS Health in Q3 2019, an estimated $1.72M increase.
- FMA Advisory's biggest Q3 2019 reduction was Johnson & Johnson, cutting an estimated $1.15M.
- FMA Advisory fully exited Nokia in Q3 2019, selling an estimated $67K.
- FMA Advisory's ten largest holdings make up 25% of its $230M portfolio in Q3 2019.
- FMA Advisory opened 7 new positions and closed 1 in Q3 2019.
- FMA Advisory's portfolio value rose 2.3% quarter-over-quarter to $230M.
Based on FMA Advisory's 13F filing for Q3 2019, filed 12 Apr 2021.